Sustainable and Bio-Derived Injectable-Grade Excipients Market Forecast with Size and Share Analysis 2026 to 2035
Segmentation of the Sustainable & Bio-Derived Injectable-Grade Excipients Market :
Sustainable & Bio-Derived Injectable-Grade Excipients Market, By Excipient Type-
- Carbohydrates
- Trehalose
- Maltose
- Sucrose
- Mannitol
- Sorbitol
- Polymers & Biopolymers
- Polyamino acids (PEG alternatives)
- PLA
- PLGA
- PCL
- HPMC (bio-based)
- Ethylcellulose (bio-based)
- Chitosan
- Lipids & Oils
- Plant-based squalene
- Phospholipids
- Sterols
- Stabilizers & Cryoprotectants
- Bio-derived antioxidants
- Amino Acids (glycine, arginine)
- Rice Bran Proteins
- Surfactants & Emulsifiers
- Super-refined Polysorbates
- Bio-based Lecithin
- Others (Bio-derived buffers, chelating agents, viscosity enhancers, etc)
Sustainable & Bio-Derived Injectable-Grade Excipients Market, By Source-
- Plant-Derived
- Corn
- Sugarcane
- Soy
- Sunflower
- Algae
- Microbial/Biotechnological
- Marine-Derived
- Alginates
- Carrageenan
- Chitosan
- Synthetic Bio-Derived
Sustainable & Bio-Derived Injectable-Grade Excipients Market, By Function in Formulation-
- Stabilizers / Protectants
- Cryoprotectants / Lyoprotectants
- Solubilizers & Permeation Enhancers
- Controlled-Release / Depot Formers
- Adjuvants for Vaccines
- Bulking Agents / Fillers
Sustainable & Bio-Derived Injectable-Grade Excipients Market, By Dosage Form-
- Parenteral Solutions (IV, IM, SC)
- Lyophilized Injectables
- Suspensions & Emulsions
- Long-Acting Injectable (LAI) Formulations
- Depot & Implantable Systems
Sustainable & Bio-Derived Injectable-Grade Excipients Market, By End-Use Application-
- Biologics & Biosimilars
- Vaccines
- Cell & Gene Therapies
- Peptide & Nucleic Acid Drugs
- Small Molecule Injectables
Sustainable & Bio-Derived Injectable-Grade Excipients Market, By Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Sustainable & Bio-Derived Injectable-Grade Excipients Market Snapshot
Chapter 4. Global Sustainable & Bio-Derived Injectable-Grade Excipients Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2026-2035
4.8. Global Sustainable & Bio-Derived Injectable-Grade Excipients Market Penetration & Growth Prospect Mapping (US$ Mn), 2025-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/impact of AI on Sustainable & Bio-Derived Injectable-Grade Excipients Market Industry Trends
Chapter 5. Sustainable & Bio-Derived Injectable-Grade Excipients Market Segmentation 1: By Excipient Type, Estimates & Trend Analysis
5.1. Market Share by Excipient Type, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2035 for the following Excipient Type:
5.2.1. Carbohydrates
5.2.1.1. Trehalose
5.2.1.2. Maltose
5.2.1.3. Sucrose
5.2.1.4. Mannitol
5.2.1.5. Sorbitol
5.2.2. Polymers & Biopolymers
5.2.2.1. Polyamino acids (PEG alternatives)
5.2.2.2. PLA
5.2.2.3. PLGA
5.2.2.4. PCL
5.2.2.5. HPMC (bio-based)
5.2.2.6. Ethylcellulose (bio-based)
5.2.2.7. Chitosan
5.2.3. Lipids & Oils
5.2.3.1. Plant-based squalene
5.2.3.2. Phospholipids
5.2.3.3. Sterols
5.2.4. Stabilizers & Cryoprotectants
5.2.4.1. Bio-derived antioxidants
5.2.4.2. Amino Acids (glycine, arginine)
5.2.4.3. Rice Bran Proteins
5.2.5. Surfactants & Emulsifiers
5.2.5.1. Super-refined Polysorbates
5.2.5.2. Bio-based Lecithin
5.2.6. Others (Bio-derived buffers, chelating agents, viscosity enhancers, etc)
Chapter 6. Sustainable & Bio-Derived Injectable-Grade Excipients Market Segmentation 2: By Source, Estimates & Trend Analysis
6.1. Market Share by Source, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2035 for the following Source:
6.2.1. Plant-Derived
6.2.1.1. Corn
6.2.1.2. Sugarcane
6.2.1.3. Soy
6.2.1.4. Sunflower
6.2.1.5. Algae
6.2.2. Microbial/Biotechnological
6.2.3. Marine-Derived
6.2.3.1. Alginates
6.2.3.2. Carrageenan
6.2.3.3. Chitosan
6.2.4. Synthetic Bio-Derived
Chapter 7. Sustainable & Bio-Derived Injectable-Grade Excipients Market Segmentation 3: By Function in Formulation, Estimates & Trend Analysis
7.1. Market Share by Function in Formulation, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2035 for the following Function in Formulation:
7.2.1. Stabilizers / Protectants
7.2.2. Cryoprotectants / Lyoprotectants
7.2.3. Solubilizers & Permeation Enhancers
7.2.4. Controlled-Release / Depot Formers
7.2.5. Adjuvants for Vaccines
7.2.6. Bulking Agents / Fillers
Chapter 8. Sustainable & Bio-Derived Injectable-Grade Excipients Market Segmentation 4: By Dosage Form, Estimates & Trend Analysis
8.1. Market Share by Dosage Form, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2035 for the following Dosage Form:
8.2.1. Parenteral Solutions (IV, IM, SC)
8.2.2. Lyophilized Injectables
8.2.3. Suspensions & Emulsions
8.2.4. Long-Acting Injectable (LAI) Formulations
8.2.5. Depot & Implantable Systems
Chapter 9. Sustainable & Bio-Derived Injectable-Grade Excipients Market Segmentation 5: By End-Use Application, Estimates & Trend Analysis
9.1. Market Share by End-Use Application, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2035 for the following End-Use Application:
9.2.1. Biologics & Biosimilars
9.2.2. Vaccines
9.2.3. Cell & Gene Therapies
9.2.4. Peptide & Nucleic Acid Drugs
9.2.5. Small Molecule Injectables
Chapter 10. Sustainable & Bio-Derived Injectable-Grade Excipients Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Sustainable & Bio-Derived Injectable-Grade Excipients Market, Regional Snapshot 2025 & 2035
10.2. North America
10.2.1. North America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Country, 2025-2035
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Excipient Type, 2025-2035
10.2.3. North America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Source, 2025-2035
10.2.4. North America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Function in Formulation, 2025-2035
10.2.5. North America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2025-2035
10.2.6. North America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by End-Use Application, 2025-2035
10.3. Europe
10.3.1. Europe Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Country, 2025-2035
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Excipient Type, 2025-2035
10.3.3. Europe Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Source, 2025-2035
10.3.4. Europe Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Function in Formulation, 2025-2035
10.3.5. Europe Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2025-2035
10.3.6. Europe Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by End-Use Application, 2025-2035
10.4. Asia Pacific
10.4.1. Asia Pacific Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Country, 2025-2035
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Excipient Type, 2025-2035
10.4.3. Asia Pacific Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Source, 2025-2035
10.4.4. Asia Pacific Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Function in Formulation, 2025-2035
10.4.5. Asia Pacific Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts By Dosage Form, 2025-2035
10.4.6. Asia Pacific Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by End-Use Application, 2025-2035
10.5. Latin America
10.5.1. Latin America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Country, 2025-2035
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Excipient Type, 2025-2035
10.5.3. Latin America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Source, 2025-2035
10.5.4. Latin America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Function in Formulation, 2025-2035
10.5.5. Latin America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2025-2035
10.5.6. Latin America Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by End-Use Application, 2025-2035
10.6. Middle East & Africa
10.6.1. Middle East & Africa Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by country, 2025-2035
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Excipient Type, 2025-2035
10.6.3. Middle East & Africa Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Source, 2025-2035
10.6.4. Middle East & Africa Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Function in Formulation, 2025-2035
10.6.5. Middle East & Africa Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2025-2035
10.6.6. Middle East & Africa Sustainable & Bio-Derived Injectable-Grade Excipients Market Revenue (US$ Million) Estimates and Forecasts by End-Use Application, 2025-2035
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Nagase Viita
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Eastman Chemical Company
11.2.3. Roquette Frères
11.2.4. Croda International / Croda Pharma
11.2.5. Evonik Industries
11.2.6. Merck KGaA
11.2.7. BASF SE
11.2.8. ADM (Archer Daniels Midland)
11.2.9. Pfanstiehl
11.2.10. Ashland
11.2.11. Clariant
11.2.12. Actylis Lab Solutions
11.2.13. CD Bioparticles
11.2.14. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Sustainable and Bio-Derived Injectable-Grade Excipients Market Size is valued at USD 1.15 Bn in 2025 and is predicted to reach USD 2.19 Bn by the year 2035
Sustainable and Bio-Derived Injectable-Grade Excipients Market is expected to grow at a 6.8% CAGR during the forecast period for 2026 to 2035
Nagase Viita, Eastman Chemical Company, Roquette Frères, Croda International / Croda Pharma, Evonik Industries, Merck KGaA, BASF SE, ADM (Archer Daniels Midland), Pfanstiehl, Ashland, Clariant, Actylis Lab Solutions, CD Bioparticles and Others.
Sustainable and Bio-Derived Injectable-Grade Excipients Market is segmented into Excipient Type, Source, Function in Formulation, Dosage Form, End-Use Application and Other.
North America region is leading the Sustainable and Bio-Derived Injectable-Grade Excipients Market.